HUP0203473A2 - 6,9-Bisz-[(2-aminoetil)amino]benzo[g]izokinolin-5,10-dion-dimaleát liposzómás készítmény - Google Patents

6,9-Bisz-[(2-aminoetil)amino]benzo[g]izokinolin-5,10-dion-dimaleát liposzómás készítmény

Info

Publication number
HUP0203473A2
HUP0203473A2 HU0203473A HUP0203473A HUP0203473A2 HU P0203473 A2 HUP0203473 A2 HU P0203473A2 HU 0203473 A HU0203473 A HU 0203473A HU P0203473 A HUP0203473 A HU P0203473A HU P0203473 A2 HUP0203473 A2 HU P0203473A2
Authority
HU
Hungary
Prior art keywords
isoquinoline
aminoethyl
benzo
bis
amino
Prior art date
Application number
HU0203473A
Other languages
English (en)
Inventor
Carlo Bugatti
Original Assignee
Novuspharma S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novuspharma S.P.A. filed Critical Novuspharma S.P.A.
Publication of HUP0203473A2 publication Critical patent/HUP0203473A2/hu
Publication of HUP0203473A3 publication Critical patent/HUP0203473A3/hu

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/473Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

A találmány az (1) képletű 6,9-Bisz-[(2-aminoetil)-amino]-benzo[g]izokinolin-5,10-dion-dimaleát (BBR 2778) vegyület liposzómásgyógyászati készítményére vonatkozik, amelyben a liposzómákfoszfatidilkolint, koleszterint és BBR 2778 vegyületet tartalmaznak,ahol a koleszterin/foszfolipid tömegarány 1:2 és 1:7 közötti, és a BBR2778/foszfolipid tömegarány 1:4 és 1:25 közötti. A találmány tárgyatovábbá a liposzómás készítmény alkalmazása daganatellenes gyógyszerelőállítására. Ó
HU0203473A 1999-10-22 2000-10-19 Liposome composition of 6,9-bis-[(2-aminoethyl)-amino]benzo[g]isoquinoline-5,10-dione dimaleate HUP0203473A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI002219A IT1315253B1 (it) 1999-10-22 1999-10-22 Preparazione liposomiale di 6,9-bis-(2-amminoetil)ammino|benzog|isochinolin-5,10-dione dimaleato
PCT/EP2000/010303 WO2001028521A2 (en) 1999-10-22 2000-10-19 Liposome formulation of 6,9-bis-[(2-aminoethyl)-amino]benzo[g]isoquinoline-5,10-dione dimaleate

Publications (2)

Publication Number Publication Date
HUP0203473A2 true HUP0203473A2 (hu) 2003-02-28
HUP0203473A3 HUP0203473A3 (en) 2003-12-29

Family

ID=11383836

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0203473A HUP0203473A3 (en) 1999-10-22 2000-10-19 Liposome composition of 6,9-bis-[(2-aminoethyl)-amino]benzo[g]isoquinoline-5,10-dione dimaleate

Country Status (23)

Country Link
US (1) US7449197B2 (hu)
EP (1) EP1221940B1 (hu)
JP (1) JP2003512313A (hu)
KR (1) KR20020063880A (hu)
CN (1) CN1164261C (hu)
AT (1) ATE335468T1 (hu)
AU (1) AU772339B2 (hu)
BR (1) BR0014881A (hu)
CA (1) CA2386143A1 (hu)
CZ (1) CZ20021388A3 (hu)
DE (1) DE60029979T2 (hu)
EA (1) EA004477B1 (hu)
ES (1) ES2269200T3 (hu)
HU (1) HUP0203473A3 (hu)
IL (2) IL149212A0 (hu)
IT (1) IT1315253B1 (hu)
MX (1) MXPA02003939A (hu)
NO (1) NO20021867D0 (hu)
NZ (1) NZ518005A (hu)
PL (1) PL197412B1 (hu)
SK (1) SK284247B6 (hu)
WO (1) WO2001028521A2 (hu)
ZA (1) ZA200203128B (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000035422A2 (en) * 1998-12-18 2000-06-22 Hadasit Medical Research Services & Development Ltd. Method of administering a compound to multi-drug resistant cells
ITMI20021040A1 (it) * 2002-05-16 2003-11-17 Novuspharma Spa Composizioni farmaceutiche iniettabili di un derivato antracenedionico ad attivita' antitumorale
CN1305881C (zh) * 2004-08-13 2007-03-21 河南工业大学 磷脂酰胆碱的制备方法
CN103479578B (zh) * 2012-06-14 2016-08-03 沈阳药科大学 一种马来酸匹杉琼的脂质体制剂及其制备工艺
CN105596295B (zh) * 2016-01-25 2018-03-16 北京博恩特药业有限公司 马来酸匹杉琼脂质体及其制备方法
CN105997896B (zh) * 2016-05-28 2019-07-05 长沙秋点兵信息科技有限公司 治疗非霍奇金淋巴瘤的注射用冻干粉及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4797285A (en) * 1985-12-06 1989-01-10 Yissum Research And Development Company Of The Hebrew University Of Jerusalem Lipsome/anthraquinone drug composition and method
JPS6442418A (en) * 1985-12-06 1989-02-14 Yissum Res Dev Co Liposome/anthraquinone drug composition and therapy therewith
MX9203808A (es) * 1987-03-05 1992-07-01 Liposome Co Inc Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos.
US5013556A (en) * 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
ES2072223B1 (es) * 1993-11-25 1996-03-16 Lipotec Sa Liposomas encapsulando doxorubicina.
US5776488A (en) * 1994-03-11 1998-07-07 Yoshitomi Pharmaceutical Industries, Ltd. Liposome preparation
US5587382A (en) * 1994-03-28 1996-12-24 Boehringer Mannheim Italia, Spa 6,9-bis[(2-aminoethyl) amino]benzo [g]isoquinoline-5,10- dione dimaleate; an aza-anthracenedione with reduced cardiotoxicity
US5506232A (en) * 1994-03-28 1996-04-09 Boehringer Mannheim Italia S.P.A. 6,9-bis[(2-aminoethyl)amino]benzo[g]isoquinoline-5,10-dione and its dimaleate salt
EP1009383A1 (en) * 1997-09-04 2000-06-21 Biozone Laboratories, Inc. Oral liposomal delivery system

Also Published As

Publication number Publication date
EA200200389A1 (ru) 2002-08-29
CN1382039A (zh) 2002-11-27
EP1221940A2 (en) 2002-07-17
US7449197B2 (en) 2008-11-11
DE60029979T2 (de) 2007-02-22
AU772339B2 (en) 2004-04-22
IL149212A0 (en) 2002-11-10
AU1514601A (en) 2001-04-30
ATE335468T1 (de) 2006-09-15
EP1221940B1 (en) 2006-08-09
NO20021867L (no) 2002-04-19
JP2003512313A (ja) 2003-04-02
BR0014881A (pt) 2002-06-11
IT1315253B1 (it) 2003-02-03
KR20020063880A (ko) 2002-08-05
US20060078607A1 (en) 2006-04-13
SK5382002A3 (en) 2002-09-10
DE60029979D1 (de) 2006-09-21
IL149212A (en) 2006-12-10
CZ20021388A3 (cs) 2002-08-14
HUP0203473A3 (en) 2003-12-29
WO2001028521A2 (en) 2001-04-26
NZ518005A (en) 2003-10-31
CA2386143A1 (en) 2001-04-26
WO2001028521A3 (en) 2002-04-25
ZA200203128B (en) 2003-06-05
NO20021867D0 (no) 2002-04-19
SK284247B6 (sk) 2004-12-01
ITMI992219A1 (it) 2001-04-22
EA004477B1 (ru) 2004-04-29
PL197412B1 (pl) 2008-03-31
MXPA02003939A (es) 2004-06-25
CN1164261C (zh) 2004-09-01
PL354610A1 (en) 2004-02-09
ES2269200T3 (es) 2007-04-01

Similar Documents

Publication Publication Date Title
HUP0203514A2 (hu) Kinuklidin vegyületek és ezeket tartalmazó gyógyszerkészítmények és eljárás a vegyületek előállítására
TR200001542T2 (tr) Mide fundusunu gevşetici özelliklere sahip (benzodioksan, benzofuran veya benzopiran) türevleri.
BR9713596A (pt) Novas preparações de medicamentos aquosas para a obtenção de aerossóis livres de gás propelente
HUP9802221A2 (hu) Parazitaellenes hatású markfortin- és paraherkvamidszármazékok
CA2322644A1 (en) Pharmaceutical composition of topiramate
NZ302013A (en) glycoprotein IIb/IIIa antagonists; medicaments
HUP0303719A2 (hu) Mitoxantron hatóanyag-tartalmú liposzómás gyógyszerkészítmények és eljárás az előállításukra
ES2166270A1 (es) Derivados de 8-fenil-6,9-dihidro-(1,2,4,)triazolo(3,4-i)purin-5-ona.
WO2006117220A3 (en) Method of administering a cationic liposomal preparation comprising paclitaxel
CA2279279A1 (en) Lipid complexes and liposomes of highly insoluble platinum complexes
BR0209845A (pt) Formas de dosagem de oxcarbazepina e processo para a preparação das mesmas
HUP0002440A2 (hu) Savas lipofil vegyületeket tartalmazó gyógyászati készítmény ön-emulgeáló formában
GR1004522B (el) Φαρμακευτικη συνθεση
CA2280253A1 (en) Use of 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4-benzoquinone
HUP0203473A2 (hu) 6,9-Bisz-[(2-aminoetil)amino]benzo[g]izokinolin-5,10-dion-dimaleát liposzómás készítmény
DE50313292D1 (de) Vernebelbare liposomen und ihre verwendung zur pulmonalen applikation von wirkstoffen
HUP0204563A2 (en) Process for preparation of 3,3-diarylpropylamine derivatives and their intermediates and their use for preparation of pharmaceutical compositions
HUP0102903A2 (hu) Nokatiacin antibiotikumok, eljárás az előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények
HUP0003571A2 (hu) 6,9-Hídkötésű eritromicin-származékok
WO2005053658A8 (fr) Capsule molle de butylphthalide et procede de preparation correspondant
MXPA02012683A (es) Composiciones farmaceuticas solidas de valsartan.
BR0111541A (pt) Formulações lipossÈmicas inibidoras de timidilato sintase de benzoquinazolina
MY133112A (en) 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use
ES2086802T3 (es) Formulaciones liposomicas de principios activos y procedimiento para su preparacion.
HUP9900438A2 (hu) Pirazolo[4,3-d]pirimidin-7-on-származékok alkalmazása gerincvelő-sérülés következtében fellépő impotencia kezelésére használható gyógyszerkészítmények előállítására

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees